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Background: Previous investigations have suggested that genetic variations are associated with
reduced lung function in early childhood. This study was conducted to evaluate the association
between IL13 þ 2044G/ A, the functionally relevant single nucleotide polymorphism (SNP) in
the gene coding IL13, and lung function in early childhood.
Patients and methods: A total of 1900 subjects aged 10e18 years living in Korea, were
randomly recruited. Lung function test and methacholine bronchial provocation test were per-
formed. Multiple regression analysis adjusting for sex, age, height, atopy, and history of
passive smoking was done to evaluate effect of IL13 þ 2044G/ A on lung function.
Results: Mean (SD) forced expiratory volume in 1 s (FEV1) was 2.66 L (0.60) in subjects with
the AA or AG genotype (nZ 982) and 2.75 L (0.57) in subjects with the GG genotype
(nZ 918). IL13 þ 2044G/ A showed a significant association with FEV1 [in the minor allele
dominant model (GG vs. AG þ AA), P < 0.001]. Interestingly, the association between FEV1
and IL13 þ 2044G/ A remained still significant in subgroup analysis according to the presence
of AHR (P < 0.001 in subjects without AHR and PZ 0.002 in subjects with AHR). Moreover,
FEV1/FVC (forced vital capacity) ratio also showed a significant association with
IL13 þ 2044G/ A in both groups (P < 0.001 in subjects without AHR and P < 0.001 in subjectsonsiveness; BMI, body mass index; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity;
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Genetic variation of IL13 as a risk factor of reduced lung function 285with AHR). This cross-sectional study demonstrates that IL13 þ 2044G/ A is significantly asso-
ciated with a reduced lung function in Korean children and adolescents.
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Longitudinal studies of children and adolescent have
demonstrated that increased airway responsiveness to
stimuli like cold air1 and methacholine,2,3 atopy,2,3 and the
presence of asthma4,5 are associated with airway limita-
tions and impaired age-related growth of lung function.
Recently, in addition to those factors, genetic variations in
IL12B6 and ADAM337 have been shown to be associated with
reduced lung function in early childhood.
Interleukin 13 (IL13) is a pleomorphic cytokine and
causes mucous metaplasia, enhanced mucin gene expres-
sion, increased tissue hyaluronic acid accumulation, and
subepithelial fibrosis.8 In particular, it is well known that
genetic polymorphisms and expression levels of IL13 are
closely related to pulmonary fibrosis,9,10 chronic obstruc-
tive pulmonary disease,11,12 and airway remodeling in
asthma.13,14 However, relatively little is known about the
effects of genetic variations in IL13 on the lung functions of
children and adolescents.
In the present cross-sectional study, we selected a non-
synonymous coding single nucleotide polymorphism (SNP) in
IL13 [þ2044G/ A (R130Q); rs20541], which has beenwidely
studied15 and shown to be functionally relevant in the
previous study.16 Moreover, this SNP was reported to be
associated with allergic diseases in Korean population.17,18
We sought to determine whether IL13 þ 2044G/ A is asso-
ciated with airway limitation manifested by a low forced
expiratory volume in 1 s (FEV1) adjusting for covariates, such
as age, gender, height, atopy and history of passive smoking
in randomly recruited Korean children and adolescents.
Materials and methods
Study subjects
All subjects enrolled in this study provided written informed
consent, and the study protocol was approved by the insti-
tutional reviewboard at Seoul National University Hospital. A
total of 2864 ethnically identical participants aged 10e
18 yearswere randomly recruited through schools located on
the southern part of Jeju Island in Korea, of whom, 1900
(66.3%) were enrolled in this study. All of them resided in
rural areas, and most of their parents lived by fishing or
cultivating fruit trees. Skin prick test using 11 common aer-
oallergens (Dermatophagoides pteronyssinus, Dermatopha-
goides farinae, dog fur, cat fur, Aspergillus, Alternaria, tree
pollen mixture, grass pollen mixture, mugwort, ragweed,
and cockroach; Allergopharma, Germany) was also per-
formed as previously described.19 Subjectswho had received
oral antihistamine during the 5 days prior to skin prick test or
had dermographism were excluded. Atopy was defined as
a positive skin prick test response (allergen/histamine ratio
>1.0 plus a mean wheal size >4 mm) to one or more aller-
gens. All 1900 subjects responded to a questionnaireconcerning risk factors, e.g., passive smoking, and a family
history of allergic diseases. None of the study subjects had
been treated or had used oral or inhaled bronchodilators.
Subjects who had contracted an upper respiratory tract
infection during the 2 week period prior to study
commencement were also excluded.
Pulmonary function test and methacholine
bronchial provocation test
FEV1 and forced vital capacity (FVC) values were deter-
mined using a microspirometer (Micro Medical Limited, UK)
in a standing position without a nose-clamp, but otherwise
according to the guidelines issued by the European Respi-
ratory Society.20 Each measurement consisted of at least
three maximal expiratory maneuvers from total lung
capacity to residual volume with variations of less than 5%
and the highest FEV1 and FVC values were used in the
analyses. Methacholine bronchial provocation test was
performed as previously described,21 and positive airway
hyperresponsiveness (AHR) was defined as a methacholine
PC20 of <16 mg/mL. The slope of the dose-response curve
(DRS), defined as the percentage fall in FEV1 at the last
dose divided by the log of the last concentration of meth-
acholine (mg/mL), was calculated for a continuous index of
airway responsiveness to methacholine.22
Genotyping
Genotyping for IL13 þ 2044G/ A was done using the high
throughput single base-pair extension method (SNP-IT
assay) using an SNPstream25K system, which was custom-
ized to automatically genotype DNA samples in 384 well
plates and provide a colorimetric readout (Orchid Biosci-
ences, NJ) as previously described.23
Statistical analysis
Association analysis was performed for IL13 þ 2044G/ A
using a genetic model approach; a minor allele dominant
model (AG þ AA vs. GG). Multiple regression analysis
adjusting for sex, age, height, atopy, and history of passive
smoking was done to evaluate the effect of
IL13 þ 2044G/ A on FEV1 and FEV1/FVC ratio. Compliance
with the HardyeWeinberg equilibrium was tested using
2  2 c2 tests. Statistical analyses were performed using
SPSS version 12.0 (SPSS, Inc., Chicago, IL). P values of less
than 0.05 were regarded significant.
Results
The characteristics of study population are presented in
Table 1. IL13 þ 2044G/ A did not deviate from Hardye
Weinberg equilibrium in our study subjects (P > 0.05).
Table 1 Characteristics of subjects enrolled in the study.
Characteristics Number of
positivity
Age, mean (range) 14.8 (10e18)
Male (%) 954 (50.2)
BMI (Kg/m2)a 19.5 (3.1)
Atopy (%) 703 (37.0)
AHR (%)b 475 (25.0)
History of passive smoking (%) 1313 (69.1)
Family history of allergic diseases (%) 376 (19.8)
a BMIZ body mass index, mean  SD.
b AHRZ airway hyperresponsiveness.
286 H.-W. Park et al.A total of 982 subjects were genotyped as AA or AG (51.7%)
and 918 subjects as GG. Methacholine AHR showed
a significant association with IL13 þ 2044G/ A. Two
hundred and seventy two subjects with the AG or AA
genotype (27.8%) and 203 subjects with the GG genotype
(22.1%) showed positive results (PZ 0.014). In terms of
DRS, IL13 þ 2044G/ A also showed a significant associa-
tion adjusting for sex, age, height, atopy, and history of
passive smoking [in the minor allele dominant model
(AG þ AA vs. GG), PZ 0.022]. Meanwhile, no association
between IL13 þ 2044G/ A and atopy was found [375
subjects with the AG or AA genotypes (37.7%) vs. 328
subjects with the GG genotype (36.2%); PZ 0.515]. So far,
there has been no report concerning the equation pre-
dicting FEV1 in normal Korean children and adolescents. In
addition, a quarter of subject enrolled in the present study
showed a positive methacholine AHR, which might be
a barrier for deriving a prediction equation directly from
them. Considering this, we decided to evaluate the asso-
ciation between IL13 þ 2044G/ A and raw values of FEV1,
itself based on multiple regression analysis adjusting for
covariates, such as sex, age, height, atopy, history of
passive smoking. Mean FEV1 (SD) was 2.66 L (0.60) in
subjects with the AA or AG genotype and 2.75 L (0.57) in
subjects with the GG genotype. Table 2 shows the results of
regression analysis. Sex, age, height, and IL13 þ 2044G/ A
(in the minor allele dominant model) were significantly
associated with FEV1 in simple regression analysis. All theTable 2 Results of regression analysis for FEV1.
Explanatory
variable
Simple
regression analysis
Multiple
regression analysisa
Coefficient P
value
Coefficient P
value
Sex 0.517 <0.001 0.295 <0.001
Age 0.283 <0.001 0.038 0.023
Height 0.722 <0.001 0.596 <0.001
Atopy 0.040 0.080 0.011 0.439
Passive smoking 0.030 0.487 0.010 0.439
IL13 þ 2044G/ Ab 0.073 0.001 0.092 <0.001
a R squareZ 0.606.
b Minor allele dominant model [AG þ AA (dummy variableZ 1)
vs. GG (dummy variableZ 2)].variables except age remained significant after multiple
regression analysis (Table 2). Because AHR was one of the
factors related with airway limitation,2,3 and the preva-
lence of AHR in the present study was significantly associ-
ated with IL13 þ 2044G/ A, subgroup analysis was
performed according to the presence of AHR.
IL13 þ 2044G/ A including sex and height showed
a significant association with FEV1 in both groups by
multiple regression analysis (P < 0.001 in subjects without
AHR and PZ 0.002 in subjects with AHR, Table 3). Mean
FEV1/FVC ratio (SD) was 0.92 (0.07) in subjects with the
AA or AG genotype and 0.97 (0.04) in subjects with the GG
genotype. Interestingly, FEV1/FVC ratio was also signifi-
cantly associated with IL13 þ 2044G/ A adjusting for sex,
age, height, atopy, and history of passive smoking (Table 4)
and subgroup analysis according to the presence of AHR
showed a significant association in both groups (Table 5).
Discussion
In this cross-sectional study, we found that
IL13 þ 2044G/ A is significantly associated with a reduced
lung function, as manifested by a low FEV1% and FEV1/FVC
ratio adjusting for covariates, such as sex, age, height,
atopy, and history of passive smoking, in Korean children
and adolescents. These significant associations were found
not only in subjects with AHR but also in subjects without
AHR. Collectively, these findings suggest that reduced
early-lung function is in part a genetically determined trait.
As mentioned earlier, the presences of asthma and AHR
are markers of impaired growth of lung function in children
and adolescents.2e5 A previous study on Korean children
showed that IL13 þ 2044G/ A was significantly associated
with methacholine AHR and asthma development18 like
results of the present study. Therefore, it is likely that
methacholine AHR rather than IL13 þ 2044G/ A is asso-
ciated with a reduced lung function. To test this, we per-
formed subgroup analysis and found that IL13 þ 2044G/ A
showed a significant association with reduced lung func-
tions in subjects with AHR or without AHR. Interestingly,
Leung et al. showed that IL13 þ 2044G/ A, combined with
ADRB2 R16G and STAT6 þ 1570C/ T significantly influ-
enced lung function growth in Chinese asthmatic childrenTable 3 Results of multiple regression analysis for FEV1
according to the presence of airway hyperresponsiveness
(AHR).
Explanatory
variable
AHRa (þ, nZ 475) AHRb (, nZ 1425)
Coefficient P value Coefficient P value
Sex 0.305 <0.001 0.289 <0.001
Age 0.030 0.424 0.039 0.038
Height 0.542 <0.001 0.617 <0.001
Atopy 0.003 0.921 0.012 0.477
Passive smoking 0.053 0.097 0.004 0.823
IL13 þ 2044G/ Ac 0.102 0.002 0.089 <0.001
a R squareZ 0.524.
b R squareZ 0.626.
c Minor allele dominant model [AG þ AA (dummy varia-
bleZ 1) vs. GG (dummy variableZ 2)].
Table 4 Results of regression analysis for FEV1/FVC ratio.
Explanatory
variable
Simple
regression
analysis
Multiple
regression
analysisa
Coefficient P
value
Coefficient P
value
Sex 0.001 0.999 0.017 0.484
Age 0.079 0.001 0.047 0.055
Height 0.077 0.001 0.065 0.013
Atopy 0.048 0.036 0.036 0.092
Passive smoking 0.011 0.646 0.147 0.883
IL13 þ 2044G/ Ab 0.409 <0.001 0.411 <0.001
a R squareZ 0.181.
b Minor allele dominant model [AG þ AA (dummy varia-
bleZ 1) vs. GG (dummy variableZ 2)].
Genetic variation of IL13 as a risk factor of reduced lung function 287after 4.5-year observation.24 A recent report revealed that
a combined effect of in utero exposure to smoking and
IL13 þ 2044G/ A on persistent wheezing in British childf-
ren.25 In addition, it was reported that IL13 þ 2044G/ A,
combined with IL4RA Q551R was significantly associated
with rapid decline in lung functions in adult smokers.26
Moreover, FEV1/FVC ratio was significantly associated with
IL13 þ 2044G/ A in the present study. As indicated
before, decreased FEV1/FVC ratio in childhood was a risk
factor for airway obstruction in young adults.27 These
findings suggest that IL13 may be a ‘‘pulmonary function
gene’’ as well as an ‘‘AHR gene’’ and IL13 þ 2044G/ A
may play an important role.
A previous study found that constitutive over-expression
of IL13 induced prominent epithelial hypertrophy in small
and conducting airways, mucus production with enhanced
airway mucin gene expression, and collagen deposition in
the subepithelial region and in the adventitia of the small
and large airways which are hall markers of airway
remodeling in asthma.8 In addition, a longitudinal pop-
ulation study conducted by Rasmussen et al.5 suggested
that airway remodeling as determined by ratio of FEV1 to
vital capacity begins in childhood and continues into adult
life. Although bronchial biopsies were not performed toTable 5 Results of multiple regression analysis for FEV1/
FVC according to the presence of airway hyper-
responsiveness (AHR).
Explanatory
variable
AHRa (þ, nZ 475) AHRb (, nZ 1425)
Coefficient P value Coefficient P value
Sex 0.049 0.312 0.005 0.865
Age 0.054 0.271 0.042 0.131
Height 0.016 0.766 0.096 0.002
Atopy 0.069 0.106 0.024 0.323
Passive smoking 0.018 0.676 0.004 0.857
IL13 þ 2044G/ Ac 0.411 <0.001 0.416 <0.001
a R squareZ 0.169.
b R squareZ 0.183.
c Minor allele dominant model [AG þ AA (dummy varia-
bleZ 1) vs. GG (dummy variableZ 2)].search for clues of airway remodeling because they are
impossible in epidemiologic studies, it is plausible that
genetic variation in IL13 results in reduced lung function
found in the present study, by promoting airway
remodeling.
The results of genetic association studies only become
solid when the functional relevancy of the genetic poly-
morphisms of interest are proven and when independent
replication confirms initial results. Previous studies have
consistently witnessed functional consequences of
IL13 þ 2044G/ A, i.e., enhancements of STAT6 phos-
phorylation and CD23 expression in monocytes and hydro-
cortisone-dependent IgE switching in B cells,16 and AHR
induction in a murine model of asthma.28 Moreover, an
important role of IL13 þ 2044G/ A in determining lung
function was proven in Asian population24 as well as
different ethnic populations.25,26 These findings plus
a sufficiently large sample size of the present study make it
possible to generalize our results that lung function during
early life is in part associated with genetic components.
Although differences according to genetic variations are
minimal in early life, these differences may become
greater when individuals grow up or confer particular
susceptibilities to respiratory diseases. If patterns of lung
function during early childhood and subsequent impair-
ments of lung function in adult life can be predicted by
analyzing genetic variations, physicians would be able to
select high-risk individuals and better plan primary
prevention.
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